Almenciol, Fe C.
HRN: 02 65 00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2023
CEFTAZIDIME 1GM (VIAL)
01/01/2023
01/07/2023
IVT
2 G
Q8h
Cap-mr; Infected Wound , R Breast; Breast Ca
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes